Efficacy of cevimeline vs. pilocarpine in the secretion of saliva: A pilot study

Jae Brimhall, Malhar A. Jhaveri, Juan Yepes

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objectives To determine the efficacy and compare the side-effects of cevimeline and pilocarpine in the secretion of saliva in patients with xerostomia. Methods A randomized, cross-over, double blind study was designed. Fifteen patients with diagnosis of xerostomia were assigned to take either 5 mg of pilocarpine or 30 mg of cevimeline three times a day for four weeks. Salivary flow rates were measured during the initial baseline, first and second month appointments. Statistical analysis was carried out with ANOVA and post hoc t-tests. Results Twelve patients completed both medication treatments. Although both medications proved to increase salivary secretion, there was no significant difference between pilocarpine and cevimeline. Also, the perceived side-effects between the two medications were similar. Conclusion Both medications increased the secretion of saliva at the end of four weeks. However, there was a slightly higher increment in saliva with pilocarpine. However, the difference was not statistically significant.

Original languageEnglish (US)
Pages (from-to)123-127
Number of pages5
JournalSpecial Care in Dentistry
Volume33
Issue number3
DOIs
StatePublished - May 1 2013
Externally publishedYes

Fingerprint

Pilocarpine
Saliva
Xerostomia
Double-Blind Method
Analysis of Variance
Appointments and Schedules
cevimeline
Therapeutics

Keywords

  • cevimeline
  • dry mouth
  • pilocarpine
  • xerostomia

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Efficacy of cevimeline vs. pilocarpine in the secretion of saliva : A pilot study. / Brimhall, Jae; Jhaveri, Malhar A.; Yepes, Juan.

In: Special Care in Dentistry, Vol. 33, No. 3, 01.05.2013, p. 123-127.

Research output: Contribution to journalArticle

Brimhall, Jae ; Jhaveri, Malhar A. ; Yepes, Juan. / Efficacy of cevimeline vs. pilocarpine in the secretion of saliva : A pilot study. In: Special Care in Dentistry. 2013 ; Vol. 33, No. 3. pp. 123-127.
@article{02516ba784be4210a679c233ad2be9b1,
title = "Efficacy of cevimeline vs. pilocarpine in the secretion of saliva: A pilot study",
abstract = "Objectives To determine the efficacy and compare the side-effects of cevimeline and pilocarpine in the secretion of saliva in patients with xerostomia. Methods A randomized, cross-over, double blind study was designed. Fifteen patients with diagnosis of xerostomia were assigned to take either 5 mg of pilocarpine or 30 mg of cevimeline three times a day for four weeks. Salivary flow rates were measured during the initial baseline, first and second month appointments. Statistical analysis was carried out with ANOVA and post hoc t-tests. Results Twelve patients completed both medication treatments. Although both medications proved to increase salivary secretion, there was no significant difference between pilocarpine and cevimeline. Also, the perceived side-effects between the two medications were similar. Conclusion Both medications increased the secretion of saliva at the end of four weeks. However, there was a slightly higher increment in saliva with pilocarpine. However, the difference was not statistically significant.",
keywords = "cevimeline, dry mouth, pilocarpine, xerostomia",
author = "Jae Brimhall and Jhaveri, {Malhar A.} and Juan Yepes",
year = "2013",
month = "5",
day = "1",
doi = "10.1111/scd.12010",
language = "English (US)",
volume = "33",
pages = "123--127",
journal = "Special Care in Dentistry",
issn = "0275-1879",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Efficacy of cevimeline vs. pilocarpine in the secretion of saliva

T2 - A pilot study

AU - Brimhall, Jae

AU - Jhaveri, Malhar A.

AU - Yepes, Juan

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Objectives To determine the efficacy and compare the side-effects of cevimeline and pilocarpine in the secretion of saliva in patients with xerostomia. Methods A randomized, cross-over, double blind study was designed. Fifteen patients with diagnosis of xerostomia were assigned to take either 5 mg of pilocarpine or 30 mg of cevimeline three times a day for four weeks. Salivary flow rates were measured during the initial baseline, first and second month appointments. Statistical analysis was carried out with ANOVA and post hoc t-tests. Results Twelve patients completed both medication treatments. Although both medications proved to increase salivary secretion, there was no significant difference between pilocarpine and cevimeline. Also, the perceived side-effects between the two medications were similar. Conclusion Both medications increased the secretion of saliva at the end of four weeks. However, there was a slightly higher increment in saliva with pilocarpine. However, the difference was not statistically significant.

AB - Objectives To determine the efficacy and compare the side-effects of cevimeline and pilocarpine in the secretion of saliva in patients with xerostomia. Methods A randomized, cross-over, double blind study was designed. Fifteen patients with diagnosis of xerostomia were assigned to take either 5 mg of pilocarpine or 30 mg of cevimeline three times a day for four weeks. Salivary flow rates were measured during the initial baseline, first and second month appointments. Statistical analysis was carried out with ANOVA and post hoc t-tests. Results Twelve patients completed both medication treatments. Although both medications proved to increase salivary secretion, there was no significant difference between pilocarpine and cevimeline. Also, the perceived side-effects between the two medications were similar. Conclusion Both medications increased the secretion of saliva at the end of four weeks. However, there was a slightly higher increment in saliva with pilocarpine. However, the difference was not statistically significant.

KW - cevimeline

KW - dry mouth

KW - pilocarpine

KW - xerostomia

UR - http://www.scopus.com/inward/record.url?scp=84876553001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876553001&partnerID=8YFLogxK

U2 - 10.1111/scd.12010

DO - 10.1111/scd.12010

M3 - Article

C2 - 23600983

AN - SCOPUS:84876553001

VL - 33

SP - 123

EP - 127

JO - Special Care in Dentistry

JF - Special Care in Dentistry

SN - 0275-1879

IS - 3

ER -